Discovery of Selective Probes and Antagonists for G Protein-Coupled Receptors FPR/FPRL1 and GPR30

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 13, 2009-09 ,pp. : 1227-1236

Bentham Science Publishers

Access to resources Recommend Favorite

Fluorescent Agonists and Antagonists for Vasopressin/Oxytocin G Protein-Coupled Receptors: Usefulness in Ligand Screening Assays and Receptor Studies

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 996-1005

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Selective Agonists and Antagonists to G Protein-Activated Inwardly Rectifying Potassium Channels: Candidate Medicines for Drug Dependence and Pain

By  

Current Neuropharmacology, Vol. 9, Iss. 1, 2011-03 ,pp. : 113-117

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk

By Janero David R   Lindsley Loren   Vemuri Venkata Kiran   Makriyannis Alexandros  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 10, 2011-10 ,pp. : 995-1025

Informa Healthcare

Access to resources Recommend Favorite

G-Protein Coupled Receptor Antagonists-1: Protease Activated Receptor-1 (PAR-1) Antagonists as Novel Cardiovascular Therapeutic Agents (Hot Topic: Structure and property Approaches in Recent Drug Discovery Guest Editor: Guo Zhu Zheng)

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 10, 2003-06 ,pp. : 1115-1123

Bentham Science Publishers

Access to resources Recommend Favorite